Evaluation of the Efficacy of Intralesional Injection of Combined Digoxin and Furosemide Versus 5 - Fluorouracil in Treatment of Plantar Warts

• Status: Recruiting
• Trial end date: 2022-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Warts are common skin infections caused by human papillomavirus (HPV), which can cause a variety of skin presentations according to its type, site and the immune status .Nongenital warts may be presented as common, plane, plantar, filiform, or mucosal warts .Most people are affected by cutaneous warts, either plantar warts or common warts .prevalence of skin warts is between 3% and 13% and plantar warts are about 30% of skin warts in western world .Majority of cases occur in adolescent and young adults

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Sohag University
• Treatments: Digoxin; Fluorouracil; Furosemide

Criteria

Inclusion Criteria:

• Age:>18 years .

• Sex: both males and females will be included.

• Confirmed diagnosis by clinical and dermoscopic examination of plantar warts will be made

Exclusion Criteria:

• Patients with history or evidenced hypersensitivity to any component used in this study.

• Pregnancy & lactating.

• Patients who receive immune suppressive therapy.

• Patients who receive any wart treatment during the last 2 months before enrollment in the study.

• Patients with systemic illness especially cardiac patients.

• Patients who refused participation in the study